GPI and COVID-19: In the analysis of COVID-19(+) and COVID-19(−) patients with ACS undergoing invasive cardiology procedures, two other factors were noteworthy: a significantly higher number of infected patients who received GPI IIb/IIIa inhibitors during the procedure and the notably lower number of stents implanted during the procedure.